Peniel M. Gumedzoe

Array ( [id] => 4103892 [patent_doc_number] => 06100280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Narcotic antagonist' [patent_app_type] => 1 [patent_app_number] => 9/085463 [patent_app_country] => US [patent_app_date] => 1998-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3697 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100280.pdf [firstpage_image] =>[orig_patent_app_number] => 085463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031859 [patent_doc_number] => 05994347 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'For a process for treatment of anxiety and tension' [patent_app_type] => 1 [patent_app_number] => 9/079802 [patent_app_country] => US [patent_app_date] => 1998-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1925 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994347.pdf [firstpage_image] =>[orig_patent_app_number] => 079802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938018 [patent_doc_number] => 05972956 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Inhibition of amyloidosis by 9-acridinones' [patent_app_type] => 1 [patent_app_number] => 9/066376 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1966 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972956.pdf [firstpage_image] =>[orig_patent_app_number] => 066376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3977522 [patent_doc_number] => 05905089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-18 [patent_title] => 'Use of sesquiterpene lactones for treatment of severe inflammatory disorders' [patent_app_type] => 1 [patent_app_number] => 9/059480 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 7223 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/905/05905089.pdf [firstpage_image] =>[orig_patent_app_number] => 059480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934505 [patent_doc_number] => 05939459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Method and composition for treating mammalian disease caused by inflammatory response' [patent_app_type] => 1 [patent_app_number] => 9/040679 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4409 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939459.pdf [firstpage_image] =>[orig_patent_app_number] => 040679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3926964 [patent_doc_number] => 05952384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Method and composition for treating mammalian diseases caused by inflammatory response' [patent_app_type] => 1 [patent_app_number] => 9/040678 [patent_app_country] => US [patent_app_date] => 1998-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4411 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952384.pdf [firstpage_image] =>[orig_patent_app_number] => 040678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938589 [patent_doc_number] => 05972992 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Injectable composition' [patent_app_type] => 1 [patent_app_number] => 9/028906 [patent_app_country] => US [patent_app_date] => 1998-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1067 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972992.pdf [firstpage_image] =>[orig_patent_app_number] => 028906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4147903 [patent_doc_number] => 06063819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels' [patent_app_type] => 1 [patent_app_number] => 9/026415 [patent_app_country] => US [patent_app_date] => 1998-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17757 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063819.pdf [firstpage_image] =>[orig_patent_app_number] => 026415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3929707 [patent_doc_number] => 05980839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Apparatus and process for conducting combinational chemical syntheses' [patent_app_type] => 1 [patent_app_number] => 9/022047 [patent_app_country] => US [patent_app_date] => 1998-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4899 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980839.pdf [firstpage_image] =>[orig_patent_app_number] => 022047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4099092 [patent_doc_number] => 06048851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Solid pharmaceutical compositions for the oral administration of gallium' [patent_app_type] => 1 [patent_app_number] => 9/015425 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3242 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048851.pdf [firstpage_image] =>[orig_patent_app_number] => 015425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217312 [patent_doc_number] => 06087354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Gallium complexes of 3-hydroxy-4-pyrones to treat cancer' [patent_app_type] => 1 [patent_app_number] => 9/015201 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3237 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087354.pdf [firstpage_image] =>[orig_patent_app_number] => 015201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3946277 [patent_doc_number] => 05998397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Gallium complexes of 3-Hydroxy-4-pyrones to treat or prevent bone disease' [patent_app_type] => 1 [patent_app_number] => 9/015200 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7348 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998397.pdf [firstpage_image] =>[orig_patent_app_number] => 015200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939939 [patent_doc_number] => 05981518 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Gallium complexes of 3-hydroxy-4-pyrones to treat or prevent calcium homeostasis disorders' [patent_app_type] => 1 [patent_app_number] => 9/015730 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7348 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981518.pdf [firstpage_image] =>[orig_patent_app_number] => 015730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048647 [patent_doc_number] => 05968922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Gallium complexes of 3-hydroxy-4-pyrones to treat or prevent hypercalcemia' [patent_app_type] => 1 [patent_app_number] => 9/015426 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968922.pdf [firstpage_image] =>[orig_patent_app_number] => 015426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927033 [patent_doc_number] => 05952389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Methods of treating tardive dyskinesia and other movement disorders' [patent_app_type] => 1 [patent_app_number] => 9/006641 [patent_app_country] => US [patent_app_date] => 1998-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6048 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952389.pdf [firstpage_image] =>[orig_patent_app_number] => 006641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010610 [patent_doc_number] => 05962480 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Drug for ameliorating brain diseases' [patent_app_type] => 1 [patent_app_number] => 8/981496 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2588 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962480.pdf [firstpage_image] =>[orig_patent_app_number] => 981496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938769 [patent_doc_number] => 05973004 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism' [patent_app_type] => 1 [patent_app_number] => 9/003337 [patent_app_country] => US [patent_app_date] => 1998-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9524 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/973/05973004.pdf [firstpage_image] =>[orig_patent_app_number] => 003337 [rel_patent_id] =>[rel_patent_doc_number] =>)